The PD-1/PD-L1 pathway is a crucial immune checkpoint that regulates immune responses and maintains self-tolerance by preventing autoimmunity. It has become a significant target in cancer immunotherapy, as its blockade can enhance the immune system's ability to attack tumor cells.